ÂÜÀòÂÒÂ×

Bob Risoleo is the General Counsel of MPM as well as of BioImpact Capital, an affiliate manager of MPM and manager of the Oncology Impact Funds, private/public funds focused on oncology as well as new modalities.

Prior to joining MPM and BioImpact Capital, Bob spent 35 years at the global law firm Sullivan and Cromwell LLP where he served as a trusted advisor to clients who relied on him to handle novel and complex transactions, including in the areas of capital markets, structured and leveraged finance, M&A, joint ventures, and corporate restructuring. Known for his deep curiosity and ability to ask incisive questions, Bob has succeeded in helping U.S. and foreign companies, sovereign governments, and multilateral institutions secure high impact outcomes in some of their most critical transactional, governance, risk management and compliance matters.

Bob received his J.D. from Yale Law School and his B.A. from Yale College. Before joining Sullivan & Cromwell, Bob served as a law clerk to Judge Edward R. Becker on the United States Court of Appeals.